Peijia Financial Statements From 2010 to 2025
| 4WO Stock | EUR 0.47 0.01 2.17% |
Check Peijia Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Peijia Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Peijia financial statements analysis is a perfect complement when working with Peijia Medical Valuation or Volatility modules.
Peijia |
Peijia Medical Limited Company Current Valuation Analysis
Peijia Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Peijia Medical Current Valuation | 490.84 M |
Most of Peijia Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Peijia Medical Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Peijia Medical Limited has a Current Valuation of 490.84 M. This is 96.58% lower than that of the Healthcare sector and 96.05% lower than that of the Medical Devices industry. The current valuation for all Germany stocks is 97.05% higher than that of the company.
Peijia Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Peijia Medical's current stock value. Our valuation model uses many indicators to compare Peijia Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Peijia Medical competition to find correlations between indicators driving Peijia Medical's intrinsic value. More Info.Peijia Medical Limited is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Peijia Medical's earnings, one of the primary drivers of an investment's value.About Peijia Medical Financial Statements
Peijia Medical stakeholders use historical fundamental indicators, such as Peijia Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Peijia Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Peijia Medical's assets and liabilities are reflected in the revenues and expenses on Peijia Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Peijia Medical Limited. Please read more on our technical analysis and fundamental analysis pages.
Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. Peijia Medical Limited was founded in 2012 and is headquartered in Suzhou, the Peoples Republic of China. PEIJIA MEDICAL operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 389 people.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Peijia Stock
Peijia Medical financial ratios help investors to determine whether Peijia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Peijia with respect to the benefits of owning Peijia Medical security.